My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Lakshmi Vilas Bank revises MCLR rates
Feb 09,2017

Lakshmi Vilas Bank has revised the Marginal Cost of Funds based lending Rate (MCLR) with effect from 09 February 2017.

The revised rates are as follows -
Overnight - 9.80%
One month - 9.80%
Three month - 9.80%

Six month - 9.75%
One year - 9.75%

Powered by Capital Market - Live News

Lupin gains after good Q3 results
Feb 09,2017

The result was announced during hours today, 9 February 2017.

Meanwhile, the BSE Sensex was up 59.78 points, or 0.21%, to 28,349.70.

On the BSE, so far 1.81 lakh shares were traded in the counter, compared with average daily volumes of 75,327 shares in the past one quarter. The stock had hit a high of Rs 1,520 and a low of Rs 1,478.70 so far during the day.

The stock hit a 52-week high of Rs 1,904.75 on 10 February 2016. The stock hit a 52-week low of Rs 1,294.05 on 29 March 2016.

The large-cap drug maker has equity capital of Rs 90.30 crore. Face value per share is Rs 2.

Lupins consolidated net sales rose 31.5% to Rs 4404.90 crore in Q3 December 2016 over Q3 December 2015.

US formulation sales increased by 53.4% to $316 million in Q3 December 2016 over Q3 December 2015. Japan sales increased by 20.3% to Rs 449.20 crore in Q3 December 2016 over Q3 December 2015.

Lupins India formulation sales grew by 11.9% to Rs 991.20 crore during Q3 December 2016 as compared to Rs 886 crore during Q3 December 2015; contributing 22% of Lupins global sales. The India formulation business decreased by 0.5% sequentially as compared to Rs 995.80 crore during Q2 September 2016.

Commenting on the results, Nilesh Gupta, managing director, Lupin, said that this has been a particularly strong year for our US Generic business. The company had another strong quarter driven by consistent growth across key markets be it the US, India, Japan, EMEA, APAC and Latin America. Lupin has made significant progress on evolving its complex generic pipeline and our stellar compliance record continues.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally. The company is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective and NSAID space and holds global leadership position in the Anti-TB segment.

Powered by Capital Market - Live News

IMP Powers announces resignation of company secretary and compliance officer
Feb 09,2017

IMP Powers announced that Sarita Parwani alais (Sarita Dharamdas Khamwani), Company Secretary cum Compliance Officer has resigned with effect from 08 February 2017.

Powered by Capital Market - Live News

Maharashtra Seamless bags Rs 421 crore order
Feb 09,2017

Maharashtra Seamless has bagged a Rs 421 crore (USD 61 million) order for supply of seamless castings to ONGC.

Powered by Capital Market - Live News

Shree Ganesh Forgings to hold board meeting
Feb 09,2017

Shree Ganesh Forgings will hold a meeting of the Board of Directors of the Company on 15 February 2017, to consider and approve the unaudited Financial Result of the Company for the Quarter ended 31 December 2016.

Powered by Capital Market - Live News

Karuturi Global to hold board meeting
Feb 09,2017

Karuturi Global will hold a meeting of the Board of Directors of the Company on 14 February 2017, to approve the Un-Audited financial results of the company for the quarter ended 31 December 2016.

Powered by Capital Market - Live News

Prism Medico & Pharmacy to hold board meeting
Feb 09,2017

Prism Medico & Pharmacy will hold a meeting of the Board of Directors of the Company on 14 February 2017, to consider and take on record the Un-audited Financial Results of the Company for the quarter ended 31 December 2016.

Powered by Capital Market - Live News

Vedavaag Systems to hold board meeting
Feb 09,2017

Vedavaag Systems will hold a meeting of the Board of Directors of the Company on 14 February 2017, to approve the Unaudited financial statements/results for the quarter ended 31 December 2016.

Powered by Capital Market - Live News

Board of Hinduja Global Solutions recommends dividend
Feb 09,2017

Hinduja Global Solutions announced that the Board of Directors of the Company at its meeting held on 8 February 2017, inter alia, have recommended the dividend of Rs 2.5 per equity Share (i.e. 25%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Max Ventures & Industries to hold board meeting
Feb 09,2017

Max Ventures & Industries will hold a meeting of the Board of Directors of the Company on 10 February 2017.

Powered by Capital Market - Live News

Alfavision Overseas to hold board meeting
Feb 09,2017

Alfavision Overseas will hold a meeting of the Board of Directors of the Company on 14 February 2017, to consider and adopt the Un- Audited Statement of Accounts for the Quarter ended 31 December 2016.

Powered by Capital Market - Live News

Jaihind Synthetics to hold board meeting
Feb 09,2017

Jaihind Synthetics will hold a meeting of the Board of Directors of the Company on 14 February 2017, to consider and adopt the Un- Audited Statement of Accounts for the Quarter ended 31 December 2016.

Powered by Capital Market - Live News

High Ground Enterprise gets upgrade in credit ratings
Feb 09,2017

High Ground Enterprise announced that the Companys credit rating has been upgraded, Brickwork Ratings has given a credit rating of BBB+ to the fund borrowing limit and a rating of A2+ to the non fund based borrowing limit to the Company.

Powered by Capital Market - Live News

Board of Wheels India declares interim dividend and appoints CFO & company secretary
Feb 09,2017

Wheels India announced that the Board of Directors of the Company at its meeting held on 09 February 2017, inter alia, has approved payment of interim dividend for the financial year ending 31 March 2017 at Rs. 5/- per share (50%) on 1,20,32,279 equity shares of Rs. 10/- each fully paid up. The Interim Dividend will be paid on or before 10 March 2017 to the shareholders / beneficial owners of the Company.

The Board of Directors appointed/designated R Raghunathan Vice president (Finance) as Chief Financial Officer and S Balasundharam Divisional Manager - Secretarial & Legal as Company Secretary and Compliance Officer with effect from 11 April 2017 due to the superannuation of S Srivathsan, CFO and Company Secretary and Compliance Officer on 10 April2017.

Powered by Capital Market - Live News

Volumes jump at J B Chemicals & Pharmaceuticals counter
Feb 09,2017

J B Chemicals & Pharmaceuticals clocked volume of 3.03 lakh shares by 13:19 IST on BSE, a 35.35-times surge over two-week average daily volume of 9,000 shares. The stock fell 0.28% to Rs 350.50.

Coffee Day Enterprises notched up volume of 7.07 lakh shares, a 26.51-fold surge over two-week average daily volume of 27,000 shares. The stock rose 8.43% to Rs 219.95.

Jagran Prakashan saw volume of 3.93 lakh shares, a 23.31-fold surge over two-week average daily volume of 17,000 shares. The stock rose 1.29% to Rs 189.10.

Parag Milk Foods clocked volume of 4.62 lakh shares, a 15.15-fold surge over two-week average daily volume of 31,000 shares. The stock rose 2.60% to Rs 288.50.

Venkys (India) saw volume of 1.27 lakh shares, a 13.59-fold rise over two-week average daily volume of 9,000 shares. The stock rose 10.99% to Rs 667.

Powered by Capital Market - Live News